CD180-Associated B-Cell Alterations in Type 1 Diabetes and the In Vitro Effects of Chlorogenic Acid: An Integrated Transcriptomic and Experimental Study. (PubMed, Int J Mol Sci) - Oct 17, 2026 - "CGA treatment was associated with changes in CD180 expression in activated B cells and improved β-cell functional outcomes in vitro. These findings support further investigation of the relationship between CGA and CD180; however, whether the effects of CGA are specifically mediated through CD180 requires further experimental validation."
Journal • Preclinical • Diabetes • Immunology • Metabolic Disorders • Type 1 Diabetes Mellitus • STEAP4
|
|
Arzu Mijit; Lufeng Cheng; Mengjia Li; Rong Han; Yang Wu; Zihang Wang
|